Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2018 06:30

Feb 14 (Reuters)-  
             Phoenixbio Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              645 mln             899 mln           1.24      
                   (-28.3 pct)         (+12.5 pct)      (+1.0 pct)   
  Operating       loss 232 mln           81 mln           52 mln     
                                       (-9.3 pct)       (-63.2 pct)  
  Recurring       loss 224 mln           72 mln           57 mln     
                                       (-14.6 pct)      (-56.9 pct)  
  Net             loss 228 mln           67 mln           48 mln     
                                       (-5.4 pct)       (-62.5 pct)  
  EPS            loss 78.68 yen         23.32 yen        16.58 yen   
  EPS Diluted                           23.09 yen                    
  Ann Div                                  NIL              NIL      
  -Q2 div              NIL                 NIL                       
  -Q4 div                                  NIL              NIL      
   
  NOTE - Phoenixbio Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T 
  ((Tokyo Headline News Desk +813 6441 1812))